HGSI Financial Facts
Income (loss) before taxes: -92.8MResearch and development expenses: 35.44M
See Full Income Statement
Total stockholders' equity: 300.65M
Accrued payroll and related taxes: 29.21M
See Full Balance Sheet
Earnings History for Human Genome Sciences Inc. (HGSI)
|
Expand Research on HGSI
| Next EPS Date | 7/20/12 *Est. | EPS Growth Rate | +31.9% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -8.4% | Revenue Growth Rate | +77.1% *Last Qtr. |
| Average % Move 1-Wk after EPS | -11.6% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/24/12  |
 |
Q112 | -$0.47 | -$0.39 | -$0.08 | $47.1M | $45.94M | N/A / N/A | N/A | -3.6% | Details |
| 2/27/12 |
|
Q411 | -$0.41 | -$0.43 | +$0.02 | $45.5M | $42.65M | N/A / N/A | N/A | +68.9% | Details |
| 10/25/11 |
|
Q311 | -$0.45 | -$0.39 | -$0.06 | $34M | $37.31M | N/A / N/A | N/A | +13% | Details |
| 7/21/11 |
|
Q211 | -$0.42 | -$0.41 | -$0.01 | $24.9M | $29.03M | N/A / N/A | N/A | -38.6% | Details |
| 4/28/11 |
Q111 | -$0.69 | -$0.48 | -$0.21 | $26.6M | $19.26M | N/A / N/A | N/A | -51.9% | Details | |
| 2/24/11 | Q410 | -$0.46 | -$0.38 | -$0.08 | $21.3M | $21.26M | N/A / N/A | N/A | -42.8% | Details | |
| 10/27/10 | Q310 | -$0.22 | -$0.36 | +$0.14 | N/A | N/A | N/A / N/A | N/A | -46.4% | Details |
